MAXYGEN INC Uncategorized Contracts & Agreements
40 Contracts & Agreements
- CERTIFICATE OF DISSOLUTION OF MAXYGEN, INC. Pursuant toSection 275 of the General Corporation Law of the State of Delaware (Filed With SEC on August 30, 2013)
- PLAN OF COMPLETE LIQUIDATION AND DISSOLUTION OF MAXYGEN, INC. (Filed With SEC on June 3, 2013)
- Maxygen, Inc. Summary of Non-Employee DirectorCompensation (effective March 9, 2010) (Filed With SEC on March 11, 2010)
- /s/ Jim Shunk (Filed With SEC on September 28, 2009)
- PERSEID THERAPEUTICS LLC CO-SALE AGREEMENT (Filed With SEC on September 21, 2009)
- - 1 - (Filed With SEC on July 1, 2009)
- MAXYGEN, INC. AMENDED AND RESTATEDCHANGE OF CONTROL AGREEMENT (Filed With SEC on July 1, 2009)
- MAXYGEN, INC. AMENDED AND RESTATEDCHANGE OF CONTROL AGREEMENT (Filed With SEC on July 1, 2009)
- /s/ MICHAEL S. RABSON (Filed With SEC on March 12, 2009)
- MAXYGEN, INC. AMENDED AND RESTATEDCHANGE OF CONTROL AGREEMENT (Filed With SEC on March 12, 2009)
- our ability to develop products suitable for commercialization (Filed With SEC on November 7, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on August 5, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on August 5, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on August 5, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on August 5, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on August 5, 2008)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on May 9, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on May 6, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on May 6, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on May 6, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on March 7, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on March 7, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on March 7, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on March 7, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on March 7, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on March 7, 2008)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on March 4, 2008)
- our ability to develop products suitable for commercialization (Filed With SEC on March 14, 2007)
- our ability to develop products suitable for commercialization (Filed With SEC on March 14, 2007)
- Exhibit No (Filed With SEC on August 25, 2006)
- Exhibit No (Filed With SEC on August 25, 2006)
- our ability to develop products suitable for commercialization (Filed With SEC on August 7, 2006)
- MAXYGEN, INC. AMENDMENT TO STOCKOPTION AGREEMENTS (Filed With SEC on June 30, 2006)
- CO-DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on March 15, 2006)
- [LOGO OF MAXYGEN] MEMORANDUM (Filed With SEC on March 24, 2005)
- Description of Goldstein Reimbursement Arrangement (Filed With SEC on February 7, 2005)
- MAXYGEN INC. DESCRIPTION OF EXECUTIVE OFFICER CASHBONUS PROGRAM (Filed With SEC on December 13, 2004)
- VERDIA, INC. (Filed With SEC on March 27, 2003)
- MAXYGEN, INC. (Filed With SEC on March 27, 2003)
- OF MAXYGEN, INC. (amended as of May 31, 2002) (Filed With SEC on August 14, 2002)
